AstraZeneca AB v. Mylan Pharmaceuticals Inc.

 
APPEAL NO.
21-1729
OP. BELOW
DCT
SUBJECT
Patent
AUTHOR
Stoll

Question(s) Presented

“Whether the established, agreed-upon ordinary meaning of a numerical term in a claim may be displaced, in the absence of lexicography or disclaimer, on the basis that it may encompass more than the most preferred disclosed embodiment.”

Posts About this Case